FDA clears first use of smartphone app for insulin delivery

Feb. 18 (UPI) — The U.S. Food and Drug Administration has cleared the primary smartphone app to deliver insulin the use of the t:connect app from Tandem Diabetes Care, Inc.

“This FDA clearance additional validates our dedication to innovation and the diabetes community by way of providing one in every of the most requested feature enhancements,” John Sheridan, president and CEO of Tandem Diabetes Care mentioned in a statement.


Leave a comment